UTAH CODE (Last Updated: January 16, 2015) |
Title 58. Occupations and Professions |
Chapter 1. Division of Occupational and Professional Licensing Act |
Part 5. Unlawful and Unprofessional Conduct - Penalties |
§ 58-1-501.7. Standards of conduct for prescription drug education -- Academic and commercial detailing.
Latest version.
-
(1) For purposes of this section: (b) "Commercial detailing" means an educational practice employed by a pharmaceutical manufacturer in which clinical information and evidence about a prescription drug is shared with health care professionals. (c) "Manufacture" is as defined in Section 58-37-2. (d) "Pharmaceutical manufacturer" is a person who manufactures a prescription drug. (2) (a) Except as provided in Subsection (3), the provisions of this section apply to an academic detailer beginning July 1, 2013. (b) An academic detailer and a commercial detailer who educate another health care provider about prescription drugs through written or oral educational material is subject to federal regulations regarding: (i) false and misleading advertising in 21 C.F.R., Part 201 (2007); (ii) prescription drug advertising in 21 C.F.R., Part 202 (2007); and (iii) the federal Office of the Inspector General's Compliance Program Guidance for Pharmaceutical Manufacturers issued in April 2003, as amended. (c) A person who is injured by a violation of this section has a private right of action against a person engaged in academic detailing, if: (i) the actions of the person engaged in academic detailing, that are a violation of this section, are: (A) the result of gross negligence by the person; or (B) willful and wanton behavior by the person; and (ii) the damages to the person are reasonable, foreseeable, and proximately caused by the violations of this section. (3) (a) For purposes of this Subsection, "accident and health insurer": (i) is as defined in Section 31A-1-301; and (ii) includes a self-funded health benefit plan and an administrator for a self-funded health benefit plan. (b) This section does not apply to a person who engages in academic detailing if that person is engaged in academic detailing on behalf of: (i) an accident and health insurer, including when an accident and health insurer contracts with or offers: (A) the state Medicaid program, including the Primary Care Network within the state's Medicaid program; (B) the Children's Health Insurance Program created in Section 26-40-103; (C) the state's high risk insurance program created in Section 31A-29-104; (D) a Medicare plan; and (E) a Medicare supplement plan; (ii) a hospital as defined in Section 26-21-2; (iii) any class of pharmacy as defined in Section 58-17b-102, including any affiliated pharmacies; (iv) an integrated health system as defined in Section 13-5b-102; or (v) a medical clinic. (c) This section does not apply to communicating or disseminating information about a prescription drug for the purpose of conducting research using prescription drugs at a health care facility as defined in Section 26-21-2, or a medical clinic.
Enacted by Chapter 100, 2013 General Session